Glassman Wealth Services’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-16
Closed -$3.25K 970
2023
Q4
$3.25K Buy
16
+10
+167% +$1.62K ﹤0.01% 1197
2023
Q3
$1.19K Sell
6
-3
-33% -$757 ﹤0.01% 1502
2023
Q2
$2.92K Buy
9
+5
+125% +$1.43K ﹤0.01% 1147
2023
Q1
$936 Hold
4
﹤0.01% 1457
2022
Q4
$1.01K Sell
4
-1
-20% -$213 ﹤0.01% 1417
2022
Q3
$1K Buy
5
+1
+25% +$201 ﹤0.01% 1432
2022
Q2
$1K Sell
4
-6
-60% -$1.2K ﹤0.01% 1439
2022
Q1
$3K Buy
10
+7
+233% +$1.6K ﹤0.01% 1139
2021
Q4
$1K Buy
+3
New +$732 ﹤0.01% 1404
2019
Q4
Sell
-8
Closed 1318
2019
Q3
$0 Buy
8
+3
+60% +$198 ﹤0.01% 1201
2019
Q2
$0 Buy
+5
New +$269 ﹤0.01% 1214

Other funds holding INSP

Glassman Wealth Services's INSP Position: Q1 2024 in Review

Glassman Wealth Services sold out of Inspire Medical Systems (INSP) in Q1 2024, closing a stake of 16 shares — an estimated $3.25K sold.

Glassman Wealth Services first reported a position in INSP in Q2 2019 and held it in 11 quarters. The position peaked at $3.25K in Q4 2023. 328 funds tracked by Wall St. Rank hold INSP as of Q1 2024.

  • Glassman Wealth Services reported no remaining Inspire Medical Systems position as of Q1 2024 after selling out during the quarter.
  • Glassman Wealth Services sold 16 Inspire Medical Systems shares in Q1 2024, an estimated $3.25K.
  • Glassman Wealth Services first reported a position in Inspire Medical Systems in Q2 2019 and held it in 11 quarters.
  • Glassman Wealth Services's Inspire Medical Systems position peaked at $3.25K in Q4 2023.
  • 328 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.